[Federal Register Volume 69, Number 115 (Wednesday, June 16, 2004)]
[Notices]
[Page 33666]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-13536]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By notice dated February 4, 2004, and published in the Federal 
Register on February 18, 2004, (69 FR 7656), Johnson Matthey, Inc., 
Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New 
Jersey 08066, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
Difenoxin (9168)...........................  I
Propiram (9649)............................  I
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Codeine (9050).............................  II
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
Meperidine (9230)..........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Alfentanil (9737)..........................  II
Sufentanil (9740)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances in 
bulk to supply to its customers.
    No comments or objections have been received. DEA has considered 
the factors in title 21, United States Code, section 823(a) and 
determined that the registration of Johnson Matthey, Inc. to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Johnson Matthey, 
Inc. to ensure that the company's registration is consistent with the 
public interest. This investigation has included inspection and testing 
of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 823 
and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office 
of Diversion Control, hereby orders that the application submitted by 
the above firm for registration as a bulk manufacturer of the basic 
classes of controlled substances listed is granted.

    Dated: May 26, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-13536 Filed 6-15-04; 8:45 am]
BILLING CODE 4410-09-M